SEC Form 4 · accession 0001179110-18-003322
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeff Frazier
Officer — EVP, Chief Human Strategy
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2018 | A | 330 | $26.02 | A | 35,776 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning September 1, 2017 and ending February 28, 2018. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on February 28, 2018.